Literature DB >> 31026510

Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.

Seshadri Balaji1, Michael P DiLorenzo2, Frank A Fish3, Susan P Etheridge4, Peter F Aziz5, Mark W Russell6, Svjetlana Tisma7, Andreas Pflaumer8, Narayanswami Sreeram9, Peter Kubus10, Ian H Law11, Michal J Kantoch12, Naomi J Kertesz13, Margaret Strieper14, Christopher C Erickson15, Jeremy P Moore16, Stephanie J Nakano17, Harinder R Singh18, Philip Chang19, Mitchell Cohen20, Anne Fournier21, Maria V Ilina22, Richard T Smith23, Frank Zimmerman24, Michaela Horndasch25, Walter Li26, Anjan Batra27, Leonardo Liberman28, Robert Hamilton29, Christopher M Janson30, Shubhayan Sanatani31, Ilana Zeltser32, George McDaniel33, Andrew D Blaufox34, Jason M Garnreiter35, Hannah Katcoff2, Maully Shah2.   

Abstract

BACKGROUND: Predictors of risk of lethal arrhythmic events (LAE) is poorly understood and may differ from adults in children with hypertrophic cardiomyopathy (HCM).
OBJECTIVE: The purpose of this study was to determine predictors of LAE in children with HCM.
METHODS: A retrospective data collection was performed on 446 children and teenagers 20 years and younger (290 [65%] male; mean age 10.1 ± 5.7 years) with idiopathic HCM from 35 centers. Patients were classified as group 1 (HCM with LAE) if having a secondary prevention implantable cardioverter-defibrillator (ICD) or primary prevention ICD with appropriate interventions or group 2 (HCM without LAE) if having a primary prevention ICD without appropriate interventions.
RESULTS: There were 152 children (34%) in group 1 and 294 (66%) in group 2. Risk factors for group 1 by univariate analysis were septal thickness, posterior left ventricular (LV) wall thickness, lower LV outflow gradient, and Q wave > 3 mm in inferior electrocardiographic leads. Factors not associated with LAE were family history of SCD, abnormal blood pressure response to exercise, and ventricular tachycardia on ambulatory electrocardiographic monitoring. Risk factors for SCD by multivariate analysis were age at ICD placement (hazard ratio [HR] 0.9; P = .0025), LV posterior wall thickness z score (HR 1.02; P < .005), and LV outflow gradient < 30 mm Hg (HR 2.0; P < .006). LV posterior wall thickness z score ≥ 5 was associated with LAE.
CONCLUSION: Risk factors for LAE appear different in children compared to adults. Conventional adult risk factors were not significant in children. Further prospective studies are needed to improve risk stratification for LAE in children with HCM.
Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Children; Defibrillator; Hypertrophic cardiomyopathy; Sudden cardiac death

Year:  2019        PMID: 31026510     DOI: 10.1016/j.hrthm.2019.04.040

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study.

Authors:  Gabrielle Norrish; Henry Chubb; Ella Field; Karen McLeod; Maria Ilina; Georgia Spentzou; Jan Till; Piers E F Daubeney; Alan Graham Stuart; Jane Matthews; Dominic Hares; Elspeth Brown; Katie Linter; Vinay Bhole; Krishnakumar Pillai; Michael Bowes; Caroline B Jones; Orhan Uzun; Amos Wong; Arthur Yue; Shankar Sadagopan; Tara Bharucha; Norah Yap; Eric Rosenthal; Sujeev Mathur; Satish Adwani; Zdenka Reinhardt; Jasveer Mangat; Juan Pablo Kaski
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

2.  Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics.

Authors:  Robert D Whitehill; Seshadri Balaji; Michael Kelleman; Stephanie F Chandler; Dominic J Abrams; Chad Mao; Peter Fischbach; Robert Campbell
Journal:  Pediatr Cardiol       Date:  2021-08-18       Impact factor: 1.655

Review 3.  What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?

Authors:  Ingegerd Östman-Smith
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21

Review 4.  A Comprehensive Assessment of Cardiomyopathies through Cardiovascular Magnetic Resonance: Focus on the Pediatric Population.

Authors:  Francesca Baessato; Cristina Romeo; Mark G Rabbat; Gianluca Pontone; Christian Meierhofer
Journal:  Diagnostics (Basel)       Date:  2022-04-19

5.  Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?

Authors:  Myriam Lafreniere-Roula; Yoav Bolkier; Laura Zahavich; Jacob Mathew; Kristen George; Judith Wilson; Elizabeth A Stephenson; Leland N Benson; Cedric Manlhiot; Seema Mital
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

6.  Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.

Authors:  Gabrielle Norrish; Tao Ding; Ella Field; Elena Cervi; Lidia Ziółkowska; Iacopo Olivotto; Diala Khraiche; Giuseppe Limongelli; Aris Anastasakis; Robert Weintraub; Elena Biagini; Luca Ragni; Terrence Prendiville; Sophie Duignan; Karen McLeod; Maria Ilina; Adrián Fernández; Chiara Marrone; Regina Bökenkamp; Anwar Baban; Peter Kubus; Piers E F Daubeney; Georgia Sarquella-Brugada; Sergi Cesar; Sabine Klaassen; Tiina H Ojala; Vinay Bhole; Constancio Medrano; Orhan Uzun; Elspeth Brown; Ferran Gran; Gianfranco Sinagra; Francisco J Castro; Graham Stuart; Gabriele Vignati; Hirokuni Yamazawa; Roberto Barriales-Villa; Luis Garcia-Guereta; Satish Adwani; Katie Linter; Tara Bharucha; Pablo Garcia-Pavia; Ana Siles; Torsten B Rasmussen; Margherita Calcagnino; Caroline B Jones; Hans De Wilde; Toru Kubo; Tiziana Felice; Anca Popoiu; Jens Mogensen; Sujeev Mathur; Fernando Centeno; Zdenka Reinhardt; Sylvie Schouvey; Costas O'Mahony; Rumana Z Omar; Perry M Elliott; Juan Pablo Kaski
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-05-02

Review 7.  Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?

Authors:  Domenico Corrado; Mark S Link; Peter J Schwartz
Journal:  Eur Heart J       Date:  2022-08-21       Impact factor: 35.855

8.  A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.

Authors:  Anastasia Miron; Myriam Lafreniere-Roula; Chun-Po Steve Fan; Katey R Armstrong; Andreea Dragulescu; Tanya Papaz; Cedric Manlhiot; Beth Kaufman; Ryan J Butts; Letizia Gardin; Elizabeth A Stephenson; Taylor S Howard; Pete F Aziz; Seshadri Balaji; Virginie Beauséjour Ladouceur; Lee N Benson; Steven D Colan; Justin Godown; Heather T Henderson; Jodie Ingles; Aamir Jeewa; John L Jefferies; Ashwin K Lal; Jacob Mathew; Emilie Jean-St-Michel; Michelle Michels; Stephanie J Nakano; Iacopo Olivotto; John J Parent; Alexandre C Pereira; Christopher Semsarian; Robert D Whitehill; Samuel G Wittekind; Mark W Russell; Jennifer Conway; Marc E Richmond; Chet Villa; Robert G Weintraub; Joseph W Rossano; Paul F Kantor; Carolyn Y Ho; Seema Mital
Journal:  Circulation       Date:  2020-05-18       Impact factor: 29.690

9.  2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.

Authors:  Maully J Shah; Michael J Silka; Jennifer N Avari Silva; Seshadri Balaji; Cheyenne M Beach; Monica N Benjamin; Charles I Berul; Bryan Cannon; Frank Cecchin; Mitchell I Cohen; Aarti S Dalal; Brynn E Dechert; Anne Foster; Roman Gebauer; M Cecilia Gonzalez Corcia; Prince J Kannankeril; Peter P Karpawich; Jeffery J Kim; Mani Ram Krishna; Peter Kubuš; Martin J LaPage; Douglas Y Mah; Lindsey Malloy-Walton; Aya Miyazaki; Kara S Motonaga; Mary C Niu; Melissa Olen; Thomas Paul; Eric Rosenthal; Elizabeth V Saarel; Massimo Stefano Silvetti; Elizabeth A Stephenson; Reina B Tan; John Triedman; Nicholas H Von Bergen; Philip L Wackel
Journal:  Indian Pacing Electrophysiol J       Date:  2021-07-29

Review 10.  Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere.

Authors:  Gabrielle Norrish; Ella Field; Juan P Kaski
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.